[go: up one dir, main page]

UA80125C2 - Medicaments containing steroids and a novel anticholinesterase drug - Google Patents

Medicaments containing steroids and a novel anticholinesterase drug Download PDF

Info

Publication number
UA80125C2
UA80125C2 UA20041109192A UA20041109192A UA80125C2 UA 80125 C2 UA80125 C2 UA 80125C2 UA 20041109192 A UA20041109192 A UA 20041109192A UA 20041109192 A UA20041109192 A UA 20041109192A UA 80125 C2 UA80125 C2 UA 80125C2
Authority
UA
Ukraine
Prior art keywords
component
inhalation
medicinal preparation
preparation according
propellant
Prior art date
Application number
UA20041109192A
Other languages
English (en)
Ukrainian (uk)
Inventor
Rolf Banholzer
Christopher John Montagu Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael P Pieper
Gerald Pohl
Richard Reichl
Georg Schpek
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of UA80125C2 publication Critical patent/UA80125C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UA20041109192A 2002-04-12 2003-09-04 Medicaments containing steroids and a novel anticholinesterase drug UA80125C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
PCT/EP2003/003668 WO2003086399A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend steroide und ein neues anticholinergikum

Publications (1)

Publication Number Publication Date
UA80125C2 true UA80125C2 (en) 2007-08-27

Family

ID=28458802

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041109192A UA80125C2 (en) 2002-04-12 2003-09-04 Medicaments containing steroids and a novel anticholinesterase drug

Country Status (29)

Country Link
EP (2) EP1496902B1 (es)
JP (1) JP4559086B2 (es)
KR (1) KR101010869B1 (es)
CN (1) CN1646126A (es)
AR (1) AR039275A1 (es)
AT (1) ATE312607T1 (es)
AU (1) AU2003216921B2 (es)
BR (1) BR0309085A (es)
CA (1) CA2481268C (es)
DE (2) DE10216429A1 (es)
DK (1) DK1496902T3 (es)
EA (1) EA008386B1 (es)
EC (1) ECSP045355A (es)
ES (1) ES2254917T3 (es)
HR (1) HRP20040943B1 (es)
IL (2) IL164391A0 (es)
ME (1) MEP54208A (es)
MX (1) MXPA04009917A (es)
MY (1) MY137045A (es)
NO (1) NO20044097L (es)
NZ (1) NZ536284A (es)
PE (1) PE20040326A1 (es)
PL (1) PL211227B1 (es)
RS (1) RS50776B (es)
TW (1) TWI311055B (es)
UA (1) UA80125C2 (es)
UY (1) UY27758A1 (es)
WO (1) WO2003086399A1 (es)
ZA (1) ZA200406751B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US7291608B2 (en) 2001-04-30 2007-11-06 Glaxo Group Limited Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
RU2440813C2 (ru) 2004-02-06 2012-01-27 Меда Фарма Гмбх Унд Ко.Кг Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SMT202000077T1 (it) 2009-05-29 2020-03-13 Pearl Therapeutics Inc Composizioni per il rilascio polmonare di antagonisti muscarinici a lunga durata e agonisti dei recettori beta-2 adrenergici a lunga durata e metodi e sistemi associati
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FR2585563B1 (fr) 1985-07-30 1993-11-12 Glaxo Group Ltd Dispositif pour administrer des medicaments a des patients
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
AU700837B2 (en) * 1995-04-28 1999-01-14 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
WO2002036106A2 (de) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden

Also Published As

Publication number Publication date
CN1646126A (zh) 2005-07-27
ES2254917T3 (es) 2006-06-16
UY27758A1 (es) 2003-11-28
RS89904A (sr) 2006-10-27
EP1621197A3 (de) 2010-01-06
MEP54208A (en) 2011-05-10
BR0309085A (pt) 2005-02-09
KR20050000391A (ko) 2005-01-03
DE10216429A1 (de) 2003-10-23
WO2003086399A1 (de) 2003-10-23
AU2003216921B2 (en) 2008-03-13
ECSP045355A (es) 2005-01-28
NO20044097L (no) 2004-11-04
HRP20040943A2 (en) 2005-04-30
MY137045A (en) 2008-12-31
EP1496902B1 (de) 2005-12-14
EA008386B1 (ru) 2007-04-27
JP4559086B2 (ja) 2010-10-06
RS50776B (sr) 2010-08-31
CA2481268A1 (en) 2003-10-23
TWI311055B (en) 2009-06-21
IL164391A (en) 2010-11-30
ATE312607T1 (de) 2005-12-15
PL371561A1 (en) 2005-06-27
KR101010869B1 (ko) 2011-01-26
ZA200406751B (en) 2006-12-27
EP1621197A2 (de) 2006-02-01
MXPA04009917A (es) 2004-12-07
NZ536284A (en) 2006-11-30
JP2005529105A (ja) 2005-09-29
CA2481268C (en) 2011-07-12
AU2003216921A1 (en) 2003-10-27
DE50301934D1 (de) 2006-01-19
DK1496902T3 (da) 2006-05-08
HRP20040943B1 (hr) 2013-05-31
PE20040326A1 (es) 2004-07-13
TW200403062A (en) 2004-03-01
PL211227B1 (pl) 2012-04-30
AR039275A1 (es) 2005-02-16
EA200401303A1 (ru) 2005-04-28
IL164391A0 (en) 2005-12-18
EP1496902A1 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
KR100940752B1 (ko) 티오트로퓸 염 및 살메테롤 염에 기초한 신규한 의약 조성물
JP4537652B2 (ja) 抗コリン作用薬及びシクレソニドをベースとする新規薬剤組成物
US20040176338A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
US7851483B2 (en) Medicaments comprising steroids and a novel anticholinergic
RU2332217C2 (ru) Ингаляционные лекарственные средства, содержащие новое антихолинергическое средство в сочетании с кортикостероидами и бетамиметиками
PL213489B1 (pl) Kompozycje farmaceutyczne zawierajace betamimetyk i nowy lek antycholinergiczny oraz zastosowanie kompozycji
EA009989B1 (ru) Лекарственное средство и его применение для лечения воспалительных и/или обструктивных заболеваний дыхательных путей
JP2004512359A (ja) 抗コリン作用薬及びコルチコステロイドをベースとする新規医薬組成物
US20040102469A1 (en) Method for reducing the mortality rate
UA80125C2 (en) Medicaments containing steroids and a novel anticholinesterase drug
US20020179087A1 (en) Pharmaceutical compositions containing an oxitropium salt and a betamimetic
RU2361586C2 (ru) Комбинация из антихолинергического средства и стероида и ее применение для лечения заболеваний дыхательных путей путем ингаляции
US20060110329A1 (en) Inhalable pharmaceutical compositions containing an anticholinergic, salmeterol, and a steroid
US20060110330A1 (en) Inhalable pharmaceutical compositions containing an anticholinergic, formoterol, and a steroid
EA007048B1 (ru) Лекарственные средства, содержащие бетамиметики и новое антихолинергическое средство
US20050059643A1 (en) Medicaments for inhalation comprising a steroid and a betamimetic
JP2007500147A (ja) ステロイド及びフルオレンカルボン酸エステルを含有する吸入用医薬品
UA80124C2 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
JP2007523116A (ja) 抗コリン作用薬及びｐｅｇｓｕｎｅｒｃｅｐｔを基にした新規な医薬組成物
JP2008530177A (ja) 抗コリン作用薬及びエチプレドノールを含有する医薬組成物